ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,046, issued on Oct. 7, was assigned to Black Diamond Therapeutics Inc. (Cambridge, Mass.).
"Alkynyl quinazoline compounds" was invented by Matthew C. Lucas (Lexington, Mass.), Fernando Padilla (Arlington, Mass.), Alexander Flohr (Basel, Switzerland), Luca Arista (Riehen, Switzerland) and Elizabeth Buck (Huntington, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds of Formula (I'):and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention ...